Socially Determined is the social risk analytics company for organizations committed to addressing the Social Determinants of Health (SDOH). Its flagship platform SocialScape® quantifies social risk factors and analyzes the impact of these factors on health and business metrics, and its team of social risk experts provides advisory services to translate these insights into actionable solutions with measurable benefits.
CancerIQ’s technology enables hospitals to identify, evaluate and manage entire patient populations based on individual genetic risk factors. By analyzing family history, running predictive risk models and automating NCCN guidelines, CancerIQ empowers community-based providers with the genetic expertise to prevent cancer or catch it early. The platform has been rapidly adopted by some of the top health systems in the country and fully integrates with genetics laboratories, EHRs, and specialty software vendors to streamline workflow, guide clinician decision making, achieve cost savings, and – most importantly – improve patient outcomes. Learn more about how CancerIQ is scaling the use of genetic testing to predict, preempt and prevent disease at canceriq.com.
Epitel is building a brain health management platform backed by powerful data analytics, starting with seizure detection.
TailorMed Medical Ltd. is a health technology company that specializes in financial navigation systems designed to assist patients and healthcare providers in managing medical expenses. Founded in 2017 and based in Tel Aviv, Israel, TailorMed offers a comprehensive platform that automates financial processes, identifies patients at financial risk, and connects them with tailored funding opportunities. Its key products include TailorMed Financial Navigation, which streamlines financial operations for healthcare centers; TailorMed Financial Insights, a reporting dashboard that tracks key performance indicators; and TailorMed Pharmacy, which simplifies the ordering and billing of medications based on individual treatment plans. By leveraging advanced algorithms and a robust data set, TailorMed aims to reduce patient financial toxicity and improve efficiencies throughout the treatment lifecycle.
Huddle Up, formerly known as DotCom Therapy, Inc., is a Madison, Wisconsin-based company that specializes in delivering teletherapy services through an integrated web-based platform. Established in 2015, it offers a range of therapies including speech therapy, occupational therapy, and mental health services, catering to school districts, private practices, enterprise health systems, and individual clients. Its speech therapy services encompass various areas such as articulation, augmentative and alternative communication, and voice therapy, while occupational therapy includes feeding therapy, fine motor skills development, and daily living skills training. Additionally, Huddle Up provides mental health services like individual and family counseling, behavior intervention plans, and vocational rehabilitation. The company emphasizes personalized care by hand-matching clients with qualified therapists for live, online sessions using computers, tablets, or smartphones.
Developer of pharmaceutical products designed to improve patient outcomes while reducing overall healthcare costs. The company's products include generic injectable, ophthalmic, and inhalation drugs that have therapeutically effective formulations and are scaled up, enabling physicians to increase available treatment choices, while improving patients' quality of life and treatment experience.
Current Health Limited, founded in 2014 and based in Edinburgh, United Kingdom, specializes in developing wearable healthcare devices that monitor patients' vital signs. These devices are designed to measure key health metrics such as oxygen saturation, respiration rate, pulse rate, temperature, motion, activity, and posture, allowing for the early identification of unwell patients and timely medical intervention. The company also offers a patient monitoring platform that facilitates home-based care by enabling patients to share daily activities, report symptoms, and respond to structured questionnaires for their healthcare providers. By focusing on remote patient management, Current Health aims to reduce healthcare risks and costs while enhancing patient engagement and monitoring. Formerly known as Snap40 Limited, the company rebranded in December 2018 to better reflect its mission.
Renovia Inc., founded in 2016 and headquartered in Boston, Massachusetts, operates in the healthcare sector, focusing on the development of medical devices aimed at alleviating incontinence in women. The company specializes in creating both diagnostic and therapeutic devices for women suffering from pelvic floor disorders. Renovia's mission is to improve the quality of life for women dealing with these common yet often overlooked health issues.
Developer of digital health platform designed for employers, providers, and managed care organizations. The company's software offers different tools, education, and guidance through digital and virtual data with the help of health assessments, and message-based and video interactions with professionals, enabling the healthcare industry to empower patients to actively engage in their health no matter their location or circumstance.
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, established in 2016. The company specializes in developing rapid tests that analyze the immune system to address significant clinical and public health challenges, particularly in the diagnosis of acute bacterial and viral infections, as well as sepsis. Utilizing patent-pending biomarkers exclusively licensed from Stanford University, Inflammatix aims to create clinically actionable results through proprietary machine-learning algorithms. In addition to its focus on acute infections and sepsis, the company is expanding its diagnostics pipeline to include tests for tropical infections, autoimmune diseases, transplant rejection, and other medical conditions, ultimately assisting healthcare providers in making informed diagnostic decisions.
Huddle Up, formerly known as DotCom Therapy, Inc., is a Madison, Wisconsin-based company that specializes in delivering teletherapy services through an integrated web-based platform. Established in 2015, it offers a range of therapies including speech therapy, occupational therapy, and mental health services, catering to school districts, private practices, enterprise health systems, and individual clients. Its speech therapy services encompass various areas such as articulation, augmentative and alternative communication, and voice therapy, while occupational therapy includes feeding therapy, fine motor skills development, and daily living skills training. Additionally, Huddle Up provides mental health services like individual and family counseling, behavior intervention plans, and vocational rehabilitation. The company emphasizes personalized care by hand-matching clients with qualified therapists for live, online sessions using computers, tablets, or smartphones.
Huddle Up, formerly known as DotCom Therapy, Inc., is a Madison, Wisconsin-based company that specializes in delivering teletherapy services through an integrated web-based platform. Established in 2015, it offers a range of therapies including speech therapy, occupational therapy, and mental health services, catering to school districts, private practices, enterprise health systems, and individual clients. Its speech therapy services encompass various areas such as articulation, augmentative and alternative communication, and voice therapy, while occupational therapy includes feeding therapy, fine motor skills development, and daily living skills training. Additionally, Huddle Up provides mental health services like individual and family counseling, behavior intervention plans, and vocational rehabilitation. The company emphasizes personalized care by hand-matching clients with qualified therapists for live, online sessions using computers, tablets, or smartphones.
PhotoniCare, Inc. is a medical device company founded in 2013 and based in Champaign, Illinois. The company develops advanced diagnostic tools aimed at improving the standard of care for patients with ear infections. Its primary product, the TOMi Scope, utilizes near-infrared light waves to provide three-dimensional views of the middle ear, allowing physicians to see beyond the eardrum. This innovative device leverages patented technology derived from bioengineering research at the University of Illinois at Urbana-Champaign, addressing the limitations of traditional otoscopes, which can only provide surface-level views. By enabling more accurate screening and diagnosis of ear diseases, PhotoniCare aims to enhance patient outcomes and streamline the diagnostic process for healthcare providers.
VIDA Diagnostics, Inc. specializes in clinical imaging software and analysis services, focusing on lung and respiratory care. The company's flagship products include LungPrint, an automated AI-powered tool that analyzes chest CT scans to assess lung physiology and functional tissue, and VIDA|precision, which provides detailed lung measurements for pulmonary clinicians. Additionally, VIDA|vision enables interactive examination of advanced quantitative imaging analysis results. The company offers comprehensive image analysis services for both academic and clinical trials, including study design, CT protocol development, and data analysis. Founded in 2004 and headquartered in Coralville, Iowa, with an office in Minneapolis, VIDA's software is FDA cleared and CE-marked, making it suitable for clinical use in multiple regions, including the US, European Economic Area, Canada, and Australia. Through its innovative solutions, VIDA aims to empower healthcare organizations and physicians to enhance patient outcomes, especially for those at risk of chronic respiratory diseases such as COPD, interstitial lung disease, lung cancer, and COVID-19.
SilverCloud Health Limited is a provider of online therapeutic solutions aimed at improving mental wellness. The company develops a platform that offers tailored clinical programs addressing various mental health issues, including emotional health. Founded in 2011 and headquartered in Boston, Massachusetts, with additional offices in Dublin, Ireland, and London, United Kingdom, SilverCloud Health delivers evidence-based digital therapies that enhance user engagement and reduce dropout rates compared to traditional online therapeutic products. By serving the healthcare, medical, and pharmaceutical sectors, SilverCloud Health enables individuals to access professional support quickly and affordably, promoting overall mental health and well-being.
CareSignal is a provider of a remote patient monitoring platform designed to enhance the performance of payers and providers in value-based care. The platform engages large patient populations through disease-specific, evidence-based automated communications via text messages and phone calls. By identifying rising-risk patients, CareSignal enables care teams to receive real-time alerts, allowing for timely prioritization and outreach. This approach helps address the needs of underserved populations and their safety-net providers, as patients can utilize their existing phones to interact with the system. Ultimately, CareSignal aims to facilitate proactive care for individuals facing chronic, behavioral, and social challenges.
Health Scholars, Inc. is a company that specializes in medical simulation training software aimed at enhancing clinical education for healthcare providers. Established in 2017 and based in Westminster, Colorado, the company offers a range of virtual reality (VR) training solutions, including pre-hospital and in-hospital Advanced Cardiovascular Life Support (ACLS) training for first responders and clinicians, respectively. Additionally, Health Scholars provides VR training focused on mitigating surgical fire risks in operating rooms. Their platform is designed to be user-friendly and scalable across healthcare systems, allowing for the effective management and delivery of interactive training content. This approach not only offers a cost-effective solution but also enriches the educational experience for medical professionals.
Pieces Technologies, Inc. is a healthcare software solutions company founded in 2015 and headquartered in Dallas, Texas. The company emerged from the work of its founder, Ruben Amarasingham, MD, at Parkland Health & Hospital System, where he developed predictive models aimed at reducing patient readmissions. This initiative led to the establishment of the non-profit research institute PCCI, which has garnered over $50 million in scientific funding. Pieces Technologies functions as a dynamic center for innovation, addressing healthcare challenges for organizations worldwide by leveraging advanced predictive analytics and technology.
Socially Determined is the social risk analytics company for organizations committed to addressing the Social Determinants of Health (SDOH). Its flagship platform SocialScape® quantifies social risk factors and analyzes the impact of these factors on health and business metrics, and its team of social risk experts provides advisory services to translate these insights into actionable solutions with measurable benefits.
Socially Determined is the social risk analytics company for organizations committed to addressing the Social Determinants of Health (SDOH). Its flagship platform SocialScape® quantifies social risk factors and analyzes the impact of these factors on health and business metrics, and its team of social risk experts provides advisory services to translate these insights into actionable solutions with measurable benefits.
410 Medical is a healthcare company based in Durham, North Carolina, founded in 2013. It specializes in developing a rapid infuser device designed to assist critically ill patients who require volume resuscitation. This innovative solution enables healthcare providers to quickly deliver fluids, including blood and other essential components, thereby enhancing the speed and efficiency of care for patients facing life-threatening conditions like sepsis and shock. The device allows for fast setup and minimizes provider fatigue, enabling a single healthcare provider to manage multiple patient care issues simultaneously. It is particularly beneficial in pre-hospital settings and emergency departments, where timely intervention is crucial and resources may be constrained.
InsightRX is a cloud-based software platform that utilizes quantitative pharmacology and machine learning to enhance individualized treatment for patients. By providing clinical decision support tools at the point of care, the platform assists healthcare professionals in optimizing treatment decisions based on real-time patient data. InsightRX integrates clinically validated pharmacokinetic models, patient physiology, pharmacogenomics, drug concentrations, and biomarkers to refine dosing strategies. It also employs disease-based pharmacodynamics models to further inform treatment choices at both individual and population levels. Founded in 2015 and headquartered in San Francisco, InsightRX aims to improve treatment effectiveness and deliver direct benefits to patients through its innovative technology.
Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.
Paradigm Diagnostics specializes in advanced cancer diagnostics and biomarker-driven clinical trials, aiming to enhance treatment options for cancer patients. Utilizing next-generation sequencing and comprehensive biomarker analysis, Paradigm assesses the genomic and proteomic characteristics of individual tumors. This information allows for a detailed understanding of the specific cancer pathways involved and the potential therapies tailored to each patient's unique tumor profile. By focusing on personalized medicine, Paradigm empowers healthcare providers to offer targeted treatment strategies, ultimately improving patient outcomes in cancer care.
Gauss Surgical, Inc. is a medical technology company that specializes in real-time blood monitoring solutions aimed at enhancing patient outcomes during surgical procedures. Founded in 2011 and headquartered in Los Altos, California, Gauss has developed a vision-based platform that accurately measures surgical blood loss using advanced algorithms and artificial intelligence. Its flagship product, Triton, includes various models tailored for different medical settings, such as Triton OR for operating rooms and Triton L&D for labor and delivery. These devices assist healthcare professionals in early recognition of hemorrhage, provide objective metrics for blood loss, and inform transfusion decisions, ultimately improving patient safety and care quality. Gauss Surgical primarily serves the healthcare sector in the United States.
Endotronix Inc. is a developer of advanced hemodynamic monitoring technologies focused on early detection of worsening heart failure. Founded in 2007 and based in Lisle, Illinois, the company specializes in miniaturized, wireless, and implantable pressure sensors that are utilized in interventional cardiovascular procedures. These sensors connect to an external measurement device and are part of a comprehensive platform that includes cloud-based disease management and outpatient hemodynamic management. Endotronix's innovative tools facilitate patient management by linking patients, clinicians, and reimbursement teams, ultimately enhancing clinical and economic outcomes. The company's technology aims to improve proactive heart management and empower health professionals to monitor patients' conditions effectively from home.
Renovia Inc., founded in 2016 and headquartered in Boston, Massachusetts, operates in the healthcare sector, focusing on the development of medical devices aimed at alleviating incontinence in women. The company specializes in creating both diagnostic and therapeutic devices for women suffering from pelvic floor disorders. Renovia's mission is to improve the quality of life for women dealing with these common yet often overlooked health issues.
Regroup Therapy, Inc. is a Chicago-based company that specializes in telemedicine solutions aimed at addressing mental healthcare shortages across the United States. Established in 2011, the company has developed a platform that connects mental and behavioral health professionals with their patients through online sessions, using live and interactive video conferencing. Regroup's services emphasize patient privacy and the confidentiality of personal health information by employing end-to-end encryption. This technology enhances access to mental health care, enabling patients to overcome challenges related to geographic distance, mobility restrictions, and the logistical burdens of in-person visits to healthcare providers.
Level Ex, Inc. is a Chicago-based company that specializes in developing virtual surgery mobile applications aimed at enhancing the skills of physicians in performing minimally invasive procedures. Its flagship product, Airway EX, serves as a training tool for mastering critical skills related to endoscopic and interventional airway procedures, addressing a variety of complex medical scenarios. Additionally, Level Ex offers Virtual Technique Guides, a surgical training platform that incorporates multiplayer interactivity, enabling surgeons to practice virtual procedures alongside medical device sales representatives in a web conferencing environment. By leveraging advanced video game technology and cognitive neuroscience, Level Ex provides a dynamic and engaging way for healthcare professionals to stay current with rare medical cases, new devices, and emerging therapies. Founded in 2015, the company focuses on improving medical training and performance through innovative digital solutions.
PatientWisdom, LLC is a digital health company based in New Haven, Connecticut, that focuses on enhancing the experience and delivery of healthcare through its innovative platform. Established in 2015, the company collects, curates, segments, and shares patient stories, enabling better understanding of patient needs prior to clinical encounters. Its platform includes three primary solutions: PatientWisdom, which helps healthcare providers comprehend what matters most to patients; ProviderWisdom, which gathers insights from clinicians to create more effective healthcare environments; and CommunityWisdom, which offers valuable insights into community health needs. By addressing the perspectives of patients, providers, researchers, and health organizations, PatientWisdom aims to foster improved engagement, reduce clinician burnout, and streamline care delivery. The company has received recognition for its patient-centered approach, being named among the Best Tech Startups in 2018 and 2019, and winning accolades at health technology competitions.
Regroup Therapy, Inc. is a Chicago-based company that specializes in telemedicine solutions aimed at addressing mental healthcare shortages across the United States. Established in 2011, the company has developed a platform that connects mental and behavioral health professionals with their patients through online sessions, using live and interactive video conferencing. Regroup's services emphasize patient privacy and the confidentiality of personal health information by employing end-to-end encryption. This technology enhances access to mental health care, enabling patients to overcome challenges related to geographic distance, mobility restrictions, and the logistical burdens of in-person visits to healthcare providers.
InsightRX is a cloud-based software platform that utilizes quantitative pharmacology and machine learning to enhance individualized treatment for patients. By providing clinical decision support tools at the point of care, the platform assists healthcare professionals in optimizing treatment decisions based on real-time patient data. InsightRX integrates clinically validated pharmacokinetic models, patient physiology, pharmacogenomics, drug concentrations, and biomarkers to refine dosing strategies. It also employs disease-based pharmacodynamics models to further inform treatment choices at both individual and population levels. Founded in 2015 and headquartered in San Francisco, InsightRX aims to improve treatment effectiveness and deliver direct benefits to patients through its innovative technology.
AVIA Health Innovation specializes in digital healthcare transformation, focusing on developing platforms and systems that enhance collaboration and knowledge sharing within the healthcare sector. The company's flagship offering, AVIA Connect, supports hospitals and health systems in identifying, selecting, and implementing innovative IT-enabled solutions that drive growth, improve operational efficiency, and enhance value. By facilitating collaboration between healthcare providers and entrepreneurs, AVIA accelerates the adoption of emerging technologies while mitigating associated risks. The company addresses critical needs in areas such as population health, clinical data insights, care model redesign, patient engagement, and operational effectiveness. Founded in 2012 and headquartered in Chicago, Illinois, AVIA serves a diverse clientele, including health systems, medical groups, health plans, and life sciences companies.
Endotronix Inc. is a developer of advanced hemodynamic monitoring technologies focused on early detection of worsening heart failure. Founded in 2007 and based in Lisle, Illinois, the company specializes in miniaturized, wireless, and implantable pressure sensors that are utilized in interventional cardiovascular procedures. These sensors connect to an external measurement device and are part of a comprehensive platform that includes cloud-based disease management and outpatient hemodynamic management. Endotronix's innovative tools facilitate patient management by linking patients, clinicians, and reimbursement teams, ultimately enhancing clinical and economic outcomes. The company's technology aims to improve proactive heart management and empower health professionals to monitor patients' conditions effectively from home.
BrightWater Medical is a mid-stage medical device company uniquely positioned to significantly impact the treatment of ureteral blockages by interventional radiologists. The company was founded by Dr. Bob Smouse, Associate Professor of Radiology & Surgery, University of Illinois College of Medicine. Dr. Smouse is a leading interventional radiologist, clinician, academic and entrepreneur, with more than 20 years of experience in interventional radiology, endovascular surgery and clinical research.
Pieces Technologies, Inc. is a healthcare software solutions company founded in 2015 and headquartered in Dallas, Texas. The company emerged from the work of its founder, Ruben Amarasingham, MD, at Parkland Health & Hospital System, where he developed predictive models aimed at reducing patient readmissions. This initiative led to the establishment of the non-profit research institute PCCI, which has garnered over $50 million in scientific funding. Pieces Technologies functions as a dynamic center for innovation, addressing healthcare challenges for organizations worldwide by leveraging advanced predictive analytics and technology.
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.
As of January 8, 2019, Pulse Therapeutics, Inc. was acquired by Ichor Vascular, Inc. Pulse Therapeutics, Inc., a medical technology company, develops magnetically-enhanced diffusion (MED) system for the treatment of stroke, heart, and other diseases. Its MED system is used to harness magnet-based technology to dissolve blood clots faster than current modalities. The company also provides MED MicroBeads that are designed to convey physician-selected agents faster to the blood clot; intravenously administered after thrombolysis therapy is initiated; and mechanical adjunct to standard of care IV thrombolysis. In addition, it offers touch screen operated MED Workstation. Pulse Therapeutics, Inc. was incorporated in 2008 and is based in St. Louis, Missouri.